SG11201700290SA - Biomarkers of polycystic kidney disease and uses thereof - Google Patents
Biomarkers of polycystic kidney disease and uses thereofInfo
- Publication number
- SG11201700290SA SG11201700290SA SG11201700290SA SG11201700290SA SG11201700290SA SG 11201700290S A SG11201700290S A SG 11201700290SA SG 11201700290S A SG11201700290S A SG 11201700290SA SG 11201700290S A SG11201700290S A SG 11201700290SA SG 11201700290S A SG11201700290S A SG 11201700290SA
- Authority
- SG
- Singapore
- Prior art keywords
- biomarkers
- kidney disease
- polycystic kidney
- polycystic
- disease
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/492—Determining multiple analytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462033031P | 2014-08-04 | 2014-08-04 | |
PCT/US2015/043497 WO2016022500A2 (en) | 2014-08-04 | 2015-08-03 | Biomarkers of polycystic kidney disease and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201700290SA true SG11201700290SA (en) | 2017-02-27 |
Family
ID=54035292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201700290SA SG11201700290SA (en) | 2014-08-04 | 2015-08-03 | Biomarkers of polycystic kidney disease and uses thereof |
Country Status (12)
Country | Link |
---|---|
US (1) | US10871495B2 (en) |
EP (1) | EP3177932B1 (en) |
JP (2) | JP6730252B2 (en) |
KR (1) | KR20170033436A (en) |
CN (1) | CN106716136B (en) |
AU (1) | AU2015301278A1 (en) |
BR (1) | BR112017002003A2 (en) |
CO (1) | CO2017001596A2 (en) |
MX (1) | MX2017001648A (en) |
RU (1) | RU2017106891A (en) |
SG (1) | SG11201700290SA (en) |
WO (1) | WO2016022500A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112018009879A2 (en) | 2015-11-18 | 2018-11-13 | Genzyme Corp | biomarker of polycystic kidney disease and its uses |
GB201719520D0 (en) * | 2017-11-24 | 2018-01-10 | Univ College Cardiff Consultants Ltd | Neuroprotectvie peptide |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60039601D1 (en) | 1999-05-24 | 2008-09-04 | Avi Biopharma Inc | ANTISENSE AGAINST C-MYC FOR THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE |
WO2006012394A1 (en) | 2004-07-21 | 2006-02-02 | Tulane University Health Sciences Center | Treatment of renal dysfunction and multiple myeloma using pacap compounds |
EP1808694A1 (en) | 2006-01-17 | 2007-07-18 | Universitätsklinikum Freiburg | Method for diagnosing polycystic kidney disease |
US20120077263A1 (en) * | 2009-06-05 | 2012-03-29 | Mayo Foundation For Medical Education And Research | Methods and materials for isolating exosomes |
CN102018702B (en) * | 2009-09-16 | 2012-07-18 | 北京大学 | New application of ginkgolide B |
EP2622095B1 (en) * | 2010-10-01 | 2016-09-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the progression and treating a chronic kidney disease in a patient |
US20130276513A1 (en) * | 2010-10-14 | 2013-10-24 | The Regents Of The University Of California | Methods for diagnosing and assessing kidney disease |
WO2014006093A1 (en) | 2012-07-03 | 2014-01-09 | Boletta Alessandra | Compounds for use in polycystic kidney disease |
MA37975B2 (en) | 2012-09-11 | 2021-03-31 | Genzyme Corp | Glucosylceramide synthase inhibitors |
-
2015
- 2015-08-03 MX MX2017001648A patent/MX2017001648A/en unknown
- 2015-08-03 WO PCT/US2015/043497 patent/WO2016022500A2/en active Application Filing
- 2015-08-03 US US15/501,496 patent/US10871495B2/en active Active
- 2015-08-03 KR KR1020177005740A patent/KR20170033436A/en unknown
- 2015-08-03 BR BR112017002003A patent/BR112017002003A2/en not_active Application Discontinuation
- 2015-08-03 SG SG11201700290SA patent/SG11201700290SA/en unknown
- 2015-08-03 CN CN201580053081.4A patent/CN106716136B/en active Active
- 2015-08-03 EP EP15757363.5A patent/EP3177932B1/en active Active
- 2015-08-03 RU RU2017106891A patent/RU2017106891A/en not_active Application Discontinuation
- 2015-08-03 AU AU2015301278A patent/AU2015301278A1/en not_active Abandoned
- 2015-08-03 JP JP2017506291A patent/JP6730252B2/en active Active
-
2017
- 2017-02-17 CO CONC2017/0001596A patent/CO2017001596A2/en unknown
-
2020
- 2020-07-01 JP JP2020113693A patent/JP7005695B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US10871495B2 (en) | 2020-12-22 |
EP3177932A2 (en) | 2017-06-14 |
CN106716136B (en) | 2020-06-23 |
WO2016022500A2 (en) | 2016-02-11 |
JP2017525955A (en) | 2017-09-07 |
JP6730252B2 (en) | 2020-07-29 |
US20170227551A1 (en) | 2017-08-10 |
EP3177932B1 (en) | 2021-07-14 |
AU2015301278A1 (en) | 2017-02-09 |
CO2017001596A2 (en) | 2017-05-19 |
MX2017001648A (en) | 2017-04-27 |
JP7005695B2 (en) | 2022-02-04 |
BR112017002003A2 (en) | 2017-12-12 |
WO2016022500A3 (en) | 2016-04-07 |
RU2017106891A (en) | 2018-09-06 |
CN106716136A (en) | 2017-05-24 |
KR20170033436A (en) | 2017-03-24 |
RU2017106891A3 (en) | 2019-03-14 |
JP2020170013A (en) | 2020-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1255067A1 (en) | Anti-c10orf54 antibodies and uses thereof | |
HK1243440A1 (en) | Anti-interleukin-33 antibodies and uses thereof | |
IL247407B (en) | Anti-egfrviii antibodies and uses thereof | |
EP3140722A4 (en) | Characterizing states of subject | |
GB201401603D0 (en) | Biomarkers | |
GB201420908D0 (en) | Biomarkers | |
HK1231555A1 (en) | Biomarker and uses thereof | |
HK1251877A1 (en) | Biomarkers and methods of prediction | |
IL251001B (en) | Anti-il-25 antibodies and uses thereof | |
SI3524234T1 (en) | Solid state forms of sofosbuvir | |
IL246979A0 (en) | Solid state forms of sofosbuvir | |
IL261906A (en) | Biomarkers of proteopathies and uses thereof | |
SG11201700290SA (en) | Biomarkers of polycystic kidney disease and uses thereof | |
ZA201803035B (en) | Biomarker of polycystic kidney disease and uses thereof | |
GB2544217B (en) | Chlorination of sucrose-6-esters | |
EP3200825A4 (en) | Antibodies against pathological forms of tdp-43 and uses thereof | |
PT3130123T (en) | Detection of manipulation of applications | |
IL249332A0 (en) | Solid state forms of sofosbuvir | |
AU2014904616A0 (en) | Biomarkers and uses thereof | |
GB201418230D0 (en) | Construction of surfaces | |
GB201414267D0 (en) | Chlorination of sucrose-6-esters | |
AU2014901825A0 (en) | Biomarker of Disease |